UK Oncology Nursing Society (UKONS)

Initial management of adult cancer patient immmunotherapy toxicity guidelines 

Society for Endocrinology Endocrine Emergency Guidance:

• Acute management of the endocrine complications of checkpoint inhibitor therapy

Society for Gastroenterology Endorsed Guidance:

• Management of immune checkpoint inhibitor-induced enterocolitis
  

The Clatterbridge Cancer Centre Liverpool Subsequent Management of Immunotherapy Toxicity Guidance:

• Arthralgia 
• Colitis 
• Dermatitis 
• Hepatitis 
• Myocarditis 
• Nephritis 
• Pneumonitis 

Joint British Diabetes Societies for Inpatient Care:

• Management of Hyperglycaemia and Steroid (Glucocorticoid) Therapy

EU - European Society for Medical Oncology (ESMO)

• Management of toxicities from immunotherapy: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

EU - European Society of Cardiology:

• 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)

US - Society for Immunotherapy of Cancer (SITC)

New guidelines in process

• Immune Checkpoint Inhibitor-related Adverse Events Immunotherapy Guideline

• Guideline PDF version 

US - American Society of Clinical Oncology

• Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update